/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
USC Cardiology 1 - Heart Failure and Transplantation, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy
Michele Senni is Director of the USC Cardiology 1 - Heart Failure and Transplantation at the Papa Giovanni XXIII Hospital in Bergamo, Italy. He has been a Fellow of the Mayo Clinic, of the European Society of Cardiology (since 2000) and of the ANMCO (Associazione Nazionale Medici Cardiologi Ospedalieri since 2001), and has served, as Global Lead Investigator, National Coordinator and Principal Investigator of numerous clinical trials, including PARADIGM, PARAGON, TITRATION, EMPHASIS-HF, RED HF. Dr Senni was Chairman of Heart Failure Working Group of ANMCO in 2009–2010.
Dr Senni has a wide range of research interests including various aspects of left-ventricular remodeling and heart failure. Some of his more recent publications have concerned the role of biomarkers for cardiac structure phenotyping in heart failure, the prognostic stratification in stable HF patients and targeted s
